Related Experiment Videos
Endometrial responses in artificial cycles: a prospective study comparing four different oestrogen dosages
T C Li1, I D Cooke, M A Warren
1Department of Obstetrics and Gynaecology, University of Sheffield, UK.
British Journal of Obstetrics and Gynaecology
|September 1, 1992
Summary
Adequate estrogen priming is crucial for normal endometrial development. A minimum daily dose of 2 mg of oestradiol valerate is likely required for optimal endometrial response in hormone replacement therapy.
Area of Science:
- Reproductive Endocrinology
- Gynecology
Background:
- Premature ovarian failure (POF) necessitates hormone replacement therapy (HRT) for endometrial health.
- Estrogen therapy aims to mimic natural hormonal cycles to support endometrial development.
Purpose of the Study:
- To compare the endometrial response to four different estrogen regimens in women with POF.
- To determine the optimal dosage and regimen for endometrial priming in HRT.
Main Methods:
- Prospective, randomized cross-over study involving 21 women with POF.
- Comparison of variable, fixed 1 mg, 2 mg, and 4 mg oestradiol valerate dosages.
- Assessment of endometrial thickness via ultrasound and biopsy, analyzed histologically, morphometrically, and immunohistochemically.
Main Results:
- Endometrial response was comparable between variable, fixed 2 mg, and fixed 4 mg oestrogen regimens.
- A suboptimal endometrial response was observed with the fixed 1 mg oestrogen dosage.
Conclusions:
- Sufficient estrogen priming, whether variable or fixed daily dosage, is essential for normal endometrial development.
- A minimum daily dose of 2 mg oestradiol valerate is likely necessary for adequate endometrial response.
- Higher doses (4 mg) did not show adverse effects and produced supra-physiological estradiol levels.